drugset / Trial / NCT06628154
Losartan and Emotional Learning
Phase 0
Recruiting
60 enrolled
University of Oxford
National Institute for Health Research, United Kingdom · collab
RandomizedParallel-groupTriple-blindBasic science
Summary
This study explores the effects of single-dose losartan (50mg) versus placebo on emotional processing in healthy volunteers.
Timeline
- Start
- 2024-08-14
- Primary completion
- 2025-07
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.